November 12, 2015Open Access

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Objective determination of PD-L1 protein levels in NSCLC reveals heterogeneity within tumors and prominent interassay variability or discordance. This could be due to different antibody affinities, limited specificity, or distinct target epitopes. Efforts to determine the clinical value of these observations are under way.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Joseph McLaughlin

Gang Han

Kurt A. Schalper

Journals

JAMA Oncology

Actions

Institutions

Yale University

Cleveland Clinic

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study